bd max enteric bacterial panel
TRANSCRIPT
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
BD MAX™ Enteric Bacterial Panel Salmonella spp. – Shigella spp. – Campylobacter spp. ( jejuni and coli)Shiga toxin-producing E. coli (STEC)
Introducing the first panel in the BD MAX portfolio for Enteric Solutions! The BD MAX Enteric Bacterial Panel detects approximately 95% of bacteria causing infectious gastroenteritis. Compared to conventional stool culture methods:
• Reducesmaterialsonaverageby60%• Savesspaceandresourcesrequiredforculture – Eliminates multiple incubators, environments and storage• EnablesimplementationofSTECrecommendations• Improvesaccuracy,efficiencyandtimetoresultswith
molecular technology• CE-IVD*
ENTERIC
Performance methods include direct culture and identification, immunoassayandalternatePCR.
Data on file - BD Diagnostics.
*CE-IVD:CEmarkedincompliancewiththeEuropeanInVitroDiagnostic Medical Device Directive 98/79/EC
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
_________
100%
99%
98%
97%
96%
95%
94%
92%
92%
91%
90%
Salmonella spp. Shigella spp. Campylobacter(jejeuni & coli)
STEC
PositivePercentAgreement
NegativePercentAgreement
BD DiagnosticsTullastrasse 8-1269126,Heidelberg,Germanywww.bd.com/de
For more information, please contact [email protected] or visit our website: www.bd.com
1Clark,Bruce.Antibiotics,HUS,andGastroenteritis.FoodSafetyNews.August16,2010. *CE-IVD:CEmarkedincompliancewiththeEuropeanInVitroDiagnosticMedicalDeviceDirective98/79/EC
BD,BDLogoandBDMAXaretrademarksofBecton,DickinsonandCompany.©2013BD XEUR5240-13PrintedinEuropeOctober2013
The Challenge
Hospitalsandlaboratoriesarefacedwithincreasingchallengesinmanagingclinician and patient needs. In the microbiology laboratory, diagnosing gastroenteritis caused by bacteriaisdemandingasthestoolbenchrequiresahighleveloftechnologistexpertise andlaborwithmultipletestingmethodsextendingthetimetoresultupto4daysormore.
Cliniciansrequiretheseresultsinamorerapidtimeframeinordertoaccuratelymanage patientssufferingfromdiseasecausedbythesebacteria.InpatientswithSTEC,administering antimicrobialtherapyiscontra-indicatedandmaycauseadversereactions,increasingtherisk ofhemolyticuremicsyndrome(HUS)whichcanhaveahighmortalityrate.1
The Solution
BDMAXEntericBacterialPanelprovidesresultsin<3hoursoncethespecimenisloadedintothesystem. Inthelaboratory,thereductionofmultiplemethods,expertiseandlaborrequiredtoperformtestingisachieved.
BD MAX™ Enteric Bacterial PanelSalmonella spp. – Shigella spp. – Campylobacter spp. ( jejuni and coli) Shiga toxin-producing E. coli (STEC)
Specimen loaded into BD MAX
RESULTS in <3HOURS
Improve patient management and experience
TARGETED SUPPORTTHERAPY
Rapid, accurate molecular diagnostics
Conventional culture based methods
24 h
rs4
8 h
rs
• Specimen inoculated to media
• Incubate
• Plate review• Workup/subculture
suspect colonies• STEC screen• XLD plate inoculation• Reincubate plates 24 hrs
• Plate review (48 hr. hold)• Subculture suspect colonies• Screen Campy plates
• Plate review (72 hr. hold)• Send to Reference or
Public Health Lab• Finalize results
72+ hrs
Catalog Number
Product Description
Regulatory Status*
442963 BD MAX™ Enteric Bacterial Panel CE-IVD*
EVOLVING
STAFF
ING
PATHOGEN
S
RESTR
ICTION
S
CONTROLS COST